论文部分内容阅读
异基因骨髓移植是白血病等致死性血液病的根治方法,然而因我国的具体国情所致,儿童极难有骨髓移植供体。故此,我们探索性应用HLA不全相合同胞脐血造血于细胞移植(CBT)治疗小儿急性淋巴性白血病1例,获得成功。现病人造血恢复,存活40余天,现将结果简要报告如下。
Allogeneic bone marrow transplantation is a radical cure for leukemia and other fatal blood diseases. However, due to the specific national conditions in China, it is extremely difficult for children to have bone marrow transplantation donors. Therefore, we explored the use of HLA incomplete phase contract umbilical cord blood hematopoietic cell transplantation (CBT) in the treatment of children with acute lymphoblastic leukemia in 1 case and achieved success. Hemopoiesis has recovered and he has survived for more than 40 days. The results are briefly reported below.